Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Nursing Pharmacology Chemotherapy Practice Exam: Latest 2024/2025 - Prof. Somuah, Exams of Pharmacology

A practice exam for nursing pharmacology, specifically focusing on chemotherapy medications. It includes multiple-choice questions with answers and explanations, covering various aspects of chemotherapy administration, side effects, monitoring, and contraindications. The exam is designed to help nursing students prepare for their studies and exams.

Typology: Exams

2024/2025

Available from 01/06/2025

top-study-aids
top-study-aids 🇺🇸

4.5

(4)

349 documents

Partial preview of the text

Download Nursing Pharmacology Chemotherapy Practice Exam: Latest 2024/2025 - Prof. Somuah and more Exams Pharmacology in PDF only on Docsity!

NURSING PHARMACOLOGY CHEMOTHERAPY

PRACTICE EXAM LATEST 2024/

GUARANTEED PASS | RATED A+

I Wish You the Best in Your Studies and Exam Revision.

1. The client with non-Hodgkin’s lymphoma is receiving Idarubicin (Idamycin). Which of the following would indicate to the nurse that the client is experiencing an adverse effect related tothe medication?  A. Dysrhythmia  B. Weight loss  C. Nausea and vomiting  D. Peripheral neuropathy Correct Answer: A. Dysrhythmia Idarubicin (Idamycin) and Daunorubicin (Daunoxome) may cause cardiotoxicity (such as dysrhythmia, fatigue, shortness of breath), cardiomyopathy, and ECG changes.  Option B: Weight gain, not weight loss is a side effect.  Option C: This is a usual side effect that can last for 2 - 3 days.  Option D: This is not a side effect related to this medication. 2. The nurse is monitoring a patient receiving an Iv infusion of an antineoplastic medication. During the infusion, the patient complains of pain and redness at the insertion site. The nurse should take which actions? Select all that apply.  A. Reinsert the IV at a distal part of the same vein.  B. Increase the flow rate of the medication.  C. Notify the physician.   D. Apply a heat or ice compress to the site.   E. Administer an antidote as prescribed.Correct Answer: C, D, & E Extravasation may occur during the infusion of chemotherapy. Signs of which are pain, redness, and swelling on the insertion site. The infusion must stop and the physician is notified. The

ataxia which are signs of cerebral dysfunction that would immediately lead to the discontinuation of the medication.  Option A: This is characterized by skin rash, swelling, redness, pain, and/or peeling of the skin on the palms of hands and soles of feet. Is usually a mild symptom that would only require a reduction of the dosage.  Option C: Diarrhea is a related sign, not constipation.  Option D: Insomnia is not a related symptom of this medication.

5. The client with non-Hodgkin’s lymphoma is being managed with vincristine (Vincasar). Which of the following indicates a side effect specific to this medication?  A. Alopecia  B. Numbness in the toes  C. Chest heaviness  D. Weight gain Correct Answer: B. Numbness in the toes A side effect specific to this medication is peripheral neuropathy. It can be manifested as numbness and tingling sensation in the finger and toes.  Option A: Alopecia occurs nearly with all the neoplastic medications.  Options C & D: These are not related to this medication. 6. A client with sarcoma is receiving Bleomycin (Blenoxane). The nurse in charge of the client expects the physician to order which diagnostic procedure?  A. Pulmonary function studies (PFT's)  B. Stress test  C. Cranial x-ray  D. Electrocardiogram (ECG) Correct Answer: A. Pulmonary function studies (PFT’s)

Bleomycin (Blenoxane) is an antitumor antibiotic that can cause interstitial pulmonary fibrosis. Pulmonary function tests and chest x-ray are done while on this treatment.  Options B, C, & D: These are not related to the specific use of this medication.

7. A male client with breast cancer is receiving Tamoxifen (Nolvadex). The nurse specifically monitors which laboratory value?  A. Activated partial thromboplastin time  B. Triglyceride level  C. Fasting blood sugar  D. Serum sodium and potassium Correct Answer: B. Triglyceride level Tamoxifen (Nolvadex) is an antineoplastic medication that may increase cholesterol, triglyceride, and calcium levels. Complete blood count, platelet count, serum calcium, cholesterol, and triglyceride level must be monitored periodically before the administration of this medication.  Options A, C, & D: These are not monitored during medication therapy. 8. The client with ovarian cancer is receiving Tamoxifen (Nolvadex). Which of the following indicates a side effect specific to this medication?  A. Weak and brittle nails  B. Facial twitching  C. Convulsions  D. Constipation Correct Answer: D. Constipation Tamoxifen (Nolvadex) is an antineoplastic medication that may increase calcium levels. Signs of hypercalcemia include constipation, abdominal pain, hypotonicity of muscle, nausea, and vomiting.  Options A, B, & C: These are signs of hypocalcemia.

 B. Gouty arthritis  C. Pulmonary embolism  D. Ischemic heart disease Correct Answer: C. Pulmonary embolism Megestrol acetate (Megace) is an antineoplastic agent that treats breast and endometrial cancer. This medication is contraindicated for patients with a history of thrombophlebitis and pulmonary embolism.  Options A, B, & D: These are not contraindicated with this medication.

12. The client is receiving cisplatin (Platinol-AQ). Which of the following side effect is related to the medication?  A. Depressed tendon reflexes  B. Photosensitivity  C. Tinnitus  D. Ptosis Correct Answer: C. Tinnitus Cisplatin (Platinol-AQ), an alkylating medication, may cause ototoxicity, tinnitus, hypokalemia, hypomagnesemia, hypocalcemia, and nephrotoxicity.  Option A: This is a sign of hypermagnesemia.  Options B & D: These are side effects not related to this medication. 13. Chemotherapy dosing is usually based on the total body surface. What should the nurse do before administering chemotherapy? o A. Get the body mass index (BMI). o B. Ask the client about intake and output. o C. Weigh and measure the height of the patient on the day of administration.

o D. Ask the client for the height and weight. Correct Answer: C. Weigh and measure the height of the patient on the day of administration. To assure that the client obtains optimal doses of chemotherapy, dosing is usually based on the total body surface (BSA), which requires an accurate current measurement of height and weight on the day of the administration.  Options A & B: These will not provide the information needed.  Option D: This will lead to an inaccurate value in determining the true body total surface.

14. The nurse is caring for a client who is receiving a chemotherapy. Which of the followingwould be expected as a result of the massive cell destruction that occurred from the chemotherapy?  A. Leukopenia  B. Anemia  C. Thrombocytopenia  D. Hyperuricemia Correct Answer: D. Hyperuricemia. Increased levels of uric acid (Hyperuricemia) in the body is common following the treatment for leukemias and lymphomas because chemotherapy results in massive cell destruction.  Options A, B, & C: These are usually noted, but an increased uric acid level is specifically related to massive cell destruction. 15. Mitomycin (Mutamycin) is prescribed to a client with colorectal cancer. All of which are theroutes of administration, except?  A. Oral  B. Intravenous  C. Intravesical

Because antineoplastic medications lower the resistance of the body, clients must be informed not to received immunizations without a health care provider’s approval.  Option B: Diarrhea as one of the common signs of antineoplastic medication needs to avoid spicy and high-fiber foods which can increase peristalsis.  Option C: Clients need to avoid aspirin to minimize the risk of bleeding.  Option D: Clients need to avoid alcohol to minimize the risk of toxicity.

18. The nurse is monitoring the laboratory results of a male client receiving antineoplastic medications. The nurse plans to initiate bleeding precautions if which laboratory is value is noted?  A. White blood cell count of 6,000/mm3.  B. Platelet count of 45,000 cells/mm3.  C. Clotting time of 8 minutes.  D. Hemoglobin count of 15g/dl. Correct Answer: B. Platelet count of 45,000 cells/mm3. The normal value for platelets is 150,000 to 450,000 cells/mm3. When the platelet count is less than 50,000 cells/mm3, minor trauma can lead to episodes of prolonged bleeding; when less than 20,000 cells/mm3, spontaneous and uncontrolled bleeding can occur.  Option A: Normal white blood cell count is 4,000 to 11,000/mm3.  Option C: Normal clotting time is 8-15 minutes.  Option D: Normal hgb is 13.5-17.5 g/dl. 19. A client is receiving methotrexate (Rheumatrex) for a series of chemotherapy. Which of the following medication should be readily available to avoid toxicity?

 A. mesna (Mesnex)  B. vigabatrin (Sabril)  C. leucovorin (Folinic acid)  D. oseltamivir (Tamiflu) Correct Answer: C. leucovorin (Folinic acid) Large doses of Methotrexate (Rheumatrex) may lead to harmful effects in the body. Leucovorin is administered to prevent its toxicity.  Option A: Mesna is given with ifosfamide to decrease the potential of ifosfamide induced cystitis.  Option B: Vigabatrin is an anticonvulsant.  Option D: Oseltamivir is an influenza antiviral medication.

20. The nurse is providing teachings to a client receiving cyclophosphamide (Cytoxan). The nurse tells the client to which of the following?  A. Eat foods rich in potassium.  B. Increase fluid intake to 2- 3 liters per day.  C. Take the medication with food.  D. Eat foods rich in purine. Correct Answer: B. Increase fluid intake to 2- 3 liters per day. Cyclophosphamide can cause hemorrhagic cystitis. Encourage the client to increase their fluid intake to 2- 3 liters per day, unless contraindicated.  Option A: This medication can cause hyperkalemia.  Option C: The medication is taken without food.